Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

By Stephanie Brown HealthDay ReporterWEDNESDAY, July 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center ...

D r. James H. Bekker made it clear while standing at a podium in front of the U.S. Food and Drug Administration (FDA) in ...

Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies.

Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

Sarepta Therapeutics faces serious FDA action after news broke of a third patient death, the FDA gets a new top drug ...

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

Analysts downgraded Sarepta as FDA pause on Elevidys raises regulatory uncertainty, leading to significant stock pressure and valuation cuts.

The FDA is taking steps to ban current prescriptions.

Becker's Hospital Review: Enloe Health Signs Medline As Med-Surg Supplier Chico, Calif.-based Enloe Health has signed a multi-year agreement naming Medline its primary vendor for ...